WO1999027930A1 - Thrombin inhibitors - Google Patents
Thrombin inhibitors Download PDFInfo
- Publication number
- WO1999027930A1 WO1999027930A1 PCT/US1998/025362 US9825362W WO9927930A1 WO 1999027930 A1 WO1999027930 A1 WO 1999027930A1 US 9825362 W US9825362 W US 9825362W WO 9927930 A1 WO9927930 A1 WO 9927930A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mammal
- blood
- pharmaceutically acceptable
- compound
- 6alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98959636A EP1039907A4 (en) | 1997-12-01 | 1998-11-25 | THROMBIN INHIBITORS |
CA002309347A CA2309347A1 (en) | 1997-12-01 | 1998-11-25 | Thrombin inhibitors |
JP2000522916A JP2001524522A (ja) | 1997-12-01 | 1998-11-25 | トロンビン阻害剤 |
AU15395/99A AU741766B2 (en) | 1997-12-01 | 1998-11-25 | Thrombin inhibitors |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6709697P | 1997-12-01 | 1997-12-01 | |
US60/067,096 | 1997-12-01 | ||
GB9809784.3 | 1998-05-07 | ||
GBGB9809784.3A GB9809784D0 (en) | 1998-05-07 | 1998-05-07 | Thrombin Inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999027930A1 true WO1999027930A1 (en) | 1999-06-10 |
Family
ID=26313616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/025362 WO1999027930A1 (en) | 1997-12-01 | 1998-11-25 | Thrombin inhibitors |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1039907A4 (ja) |
JP (1) | JP2001524522A (ja) |
AU (1) | AU741766B2 (ja) |
CA (1) | CA2309347A1 (ja) |
WO (1) | WO1999027930A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000040583A2 (de) * | 1999-01-08 | 2000-07-13 | Merck Patent Gmbh | Imidazo[4,5-c]-pyridin-4-on-derivate |
EP1124822A1 (en) * | 1998-10-30 | 2001-08-22 | Merck & Co., Inc. | Thrombin inhibitors |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
US11926616B2 (en) | 2018-03-08 | 2024-03-12 | Incyte Corporation | Aminopyrazine diol compounds as PI3K-γ inhibitors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5658930A (en) * | 1994-12-13 | 1997-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997001338A1 (en) * | 1995-06-27 | 1997-01-16 | Merck & Co., Inc. | Pyridinone-thrombin inhibitors |
CA2245811A1 (en) * | 1996-02-22 | 1997-08-28 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
-
1998
- 1998-11-25 CA CA002309347A patent/CA2309347A1/en not_active Abandoned
- 1998-11-25 AU AU15395/99A patent/AU741766B2/en not_active Ceased
- 1998-11-25 JP JP2000522916A patent/JP2001524522A/ja not_active Withdrawn
- 1998-11-25 EP EP98959636A patent/EP1039907A4/en not_active Withdrawn
- 1998-11-25 WO PCT/US1998/025362 patent/WO1999027930A1/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5658930A (en) * | 1994-12-13 | 1997-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
Non-Patent Citations (3)
Title |
---|
BANTICK J R, ET AL.: "NEW NON-PEPTIDE ANGIOTENSIN II RECEPTOR ANTAGONISTS 2: STRUCTURE - ACTIVITY RELATIONSHIPS OF A SERIES OF ANNELATED 2(1H)-PYRIDINONES", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 04, no. 01, 1 January 1994 (1994-01-01), AMSTERDAM, NL, pages 127 - 132, XP002916792, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(01)81134-3 * |
BROWN F J, ET AL.: "DESIGN OF ORALLY ACTIVE, NON-PEPTIDE INHIBITORS OF HUMAN LEUKOCYTE ELASTASE", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 37, 1 January 1994 (1994-01-01), US, pages 1259 - 1261, XP002916793, ISSN: 0022-2623, DOI: 10.1021/jm00035a004 * |
See also references of EP1039907A4 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1124822A1 (en) * | 1998-10-30 | 2001-08-22 | Merck & Co., Inc. | Thrombin inhibitors |
EP1124822A4 (en) * | 1998-10-30 | 2002-04-03 | Merck & Co Inc | THROMBIN INHIBITORS |
WO2000040583A2 (de) * | 1999-01-08 | 2000-07-13 | Merck Patent Gmbh | Imidazo[4,5-c]-pyridin-4-on-derivate |
WO2000040583A3 (de) * | 1999-01-08 | 2000-09-21 | Merck Patent Gmbh | Imidazo[4,5-c]-pyridin-4-on-derivate |
US11926616B2 (en) | 2018-03-08 | 2024-03-12 | Incyte Corporation | Aminopyrazine diol compounds as PI3K-γ inhibitors |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Also Published As
Publication number | Publication date |
---|---|
AU1539599A (en) | 1999-06-16 |
EP1039907A1 (en) | 2000-10-04 |
AU741766B2 (en) | 2001-12-06 |
CA2309347A1 (en) | 1999-06-10 |
JP2001524522A (ja) | 2001-12-04 |
EP1039907A4 (en) | 2001-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6376499B1 (en) | Thrombin inhibitors | |
US6093717A (en) | Imidazopyridine thrombin inhibitors | |
AU753479B2 (en) | Pyrazinone thrombin inhibitors | |
WO1999011267A1 (en) | Pyrazinone thrombin inhibitors | |
US6117888A (en) | Thrombin inhibitors | |
WO1998017274A1 (en) | Thrombin inhibitors | |
US6147078A (en) | Pyrazinone thrombin inhibitors | |
US6239132B1 (en) | Thrombin inhibitors | |
US6011038A (en) | Pyrazinone thrombin inhibitors | |
AU741766B2 (en) | Thrombin inhibitors | |
US6528503B2 (en) | Thrombin inhibitors | |
US6004976A (en) | Thrombin inhibitors | |
AU740447B2 (en) | Thrombin inhibitors | |
US6087373A (en) | Thrombin inhibitors | |
US6350745B1 (en) | Thrombin inhibitors | |
AU746024B2 (en) | Pyrazinone thrombin inhibitors | |
EP1027333A1 (en) | Thrombin inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GD GE HR HU ID IL IS JP KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA US UZ VN YU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2309347 Country of ref document: CA Ref country code: CA Ref document number: 2309347 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998959636 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15395/99 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 522916 Kind code of ref document: A Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1998959636 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 15395/99 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998959636 Country of ref document: EP |